Seres Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2016 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Seres Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2016 to Q4 2024.
  • Seres Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -0.5 %, a 100% decline year-over-year.
  • Seres Therapeutics, Inc. annual Return On Equity for 2024 was -0.5 %, a 100% decline from 2023.
  • Seres Therapeutics, Inc. annual Return On Equity for 2023 was 534 %.
  • Seres Therapeutics, Inc. annual Return On Equity for 2022 was -549 %, a 1055% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -0.5 -534 -100% Oct 1, 2024 Dec 31, 2024
Q3 2024 60.8 -1.85K -96.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 314 +1.47K Apr 1, 2024 Jun 30, 2024
Q1 2024 341 +2.32K Jan 1, 2024 Mar 31, 2024
Q4 2023 534 +1.08K Oct 1, 2023 Dec 31, 2023
Q3 2023 1.91K +2.21K Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.16K -1.06K -1052% Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.98K -1.91K -2688% Jan 1, 2023 Mar 31, 2023
Q4 2022 -549 -501 -1055% Oct 1, 2022 Dec 31, 2022
Q3 2022 -305 -283 -1243% Jul 1, 2022 Sep 30, 2022
Q2 2022 -100 -13.2 -15.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -70.9 +24.1 +25.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -47.5 +104 +68.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -22.7 +2.85K +99.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -87.1 -233 -160% Apr 1, 2021 Jun 30, 2021
Q1 2021 -95 -259 -158% Jan 1, 2021 Mar 31, 2021
Q4 2020 -151 -318 -191% Oct 1, 2020 Dec 31, 2020
Q3 2020 -2.87K -3.04K -1756% Jul 1, 2020 Sep 30, 2020
Q2 2020 146 -42.4 -22.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 164 -71.5 -30.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 167 -317 -65.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 173 +1.76K Jul 1, 2019 Sep 30, 2019
Q2 2019 188 +444 Apr 1, 2019 Jun 30, 2019
Q1 2019 236 +386 Jan 1, 2019 Mar 31, 2019
Q4 2018 484 +587 Oct 1, 2018 Dec 31, 2018
Q3 2018 -1.58K -1.5K -1830% Jul 1, 2018 Sep 30, 2018
Q2 2018 -256 -176 -219% Apr 1, 2018 Jun 30, 2018
Q1 2018 -150 -81.6 -118% Jan 1, 2018 Mar 31, 2018
Q4 2017 -103 -46.6 -81.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -82.1 -34.1 -71.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 -80.2 -38.5 -92.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -68.9 -31.5 -84.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -56.9 Oct 1, 2016 Dec 31, 2016
Q3 2016 -48 Jul 1, 2016 Sep 30, 2016
Q2 2016 -41.7 Apr 1, 2016 Jun 30, 2016
Q1 2016 -37.4 Jan 1, 2016 Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.